Please Wait.....
Report
Companion Animal Drugs Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
Market Report I 2025-03-20 I 134 Pages I Global Market Insights
The Global Companion Animal Drugs Market was valued at USD 25.6 billion in 2024 and is expected to grow at a CAGR of 6.8% from 2025 to 2034. The increasing adoption of companion animals, the rising prevalence of chronic diseases in pets, and the growing willingness of pet owners to invest in advanced treatments and veterinary care are fueling this growth. Pet owners increasingly perceive their animals as family members, prompting them to spend on preventive care, vaccinations, and medications to ensure their well-being. This shift in attitude has contributed significantly to the expansion of the market. As veterinary science continues to advance, innovative formulations, targeted therapies, and improved drug delivery methods are enhancing treatment efficacy and compliance among pet owners, thereby accelerating market growth.
The drugs segment, which accounted for the highest market share of USD 13.8 billion in 2024, continues to dominate the market due to the rising incidence of chronic diseases and infections in pets. Increased pet ownership and the growing trend of pet humanization have boosted the demand for antibiotics, anti-inflammatory drugs, and parasiticides. Pharmaceutical companies are actively investing in research and development to introduce novel formulations such as chewable tablets and flavored medications, making administration easier and improving compliance. Regulatory approvals and innovations in veterinary medicine have also played a pivotal role in driving the sustained growth of this segment.
By animal type, the dogs segment maintained the largest revenue share of 54.2% in 2024, driven by high adoption rates and increased spending on dog care. Growing awareness of chronic diseases among dogs, such as cancer and diabetes, has led to a higher demand for advanced treatments and medications. The rising prevalence of these conditions highlights the need for effective therapies, encouraging pharmaceutical companies to develop specialized drugs targeting canine health. The availability of comprehensive healthcare options and increased expenditure by pet owners further bolster segment growth.
The injectable route of administration, which held the largest market share in 2024, is anticipated to witness significant growth at a CAGR of 6.3% during the forecast period. Injectable drugs, including vaccines, antibiotics, and analgesics, offer rapid onset of action and precise dosing, making them ideal for emergency treatments. Advancements in injectable drug delivery technologies and the introduction of needle-free injectors have enhanced convenience and reduced stress for both pets and their owners, contributing to the growing preference for this route.
Veterinary hospital pharmacies dominated the distribution channel in 2024 and are projected to grow at a CAGR of 6.6% from 2025 to 2034. These pharmacies offer a wide range of animal healthcare products, including prescription drugs, vaccines, and supplements, making them a reliable source for pet owners. Their established reputation, quality assurance, and expertise in dispensing medications drive their continued dominance in the market.
North America accounted for the largest market share of 41.1% in 2024, with the U.S. generating USD 9.1 billion in revenue. The region benefits from a well-developed veterinary healthcare system, high pet ownership rates, and increased spending on pet healthcare, supporting the continuous growth of the companion animal drugs market. The presence of leading pharmaceutical companies further ensures a steady supply of innovative and effective drugs, driving the expansion of the market in this region.
Report Content
Chapter 1 Methodology And Scope
1.1 Market scope and definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates and calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 360 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Surging demand for pet insurance policies worldwide
3.2.1.2 Rising rate of obesity in companion animals
3.2.1.3 Increasing government support for pet care across the globe
3.2.1.4 Growing demand for online veterinary pharmacies
3.2.2 Industry pitfalls and challenges
3.2.2.1 High cost associated with companion animal drugs
3.3 Growth potential analysis
3.4 Regulatory landscape
3.4.1 North America
3.4.2 Europe
3.4.3 Asia Pacific
3.5 GAP analysis
3.6 Consumer behaviour trends
3.7 Porter's analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2024
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)
5.1 Key trends
5.2 Drugs
5.2.1 Antiparasitic
5.2.2 Anti-inflammatory
5.2.3 Anti-infectives
5.2.4 Corticosteroids
5.2.5 Tranquilizers
5.2.6 Cardiovascular drugs
5.2.7 Gastrointestinal drugs
5.3 Vaccines
5.3.1 Modified live vaccines (MLV)
5.3.2 Killed inactivated vaccines
5.3.3 Recombinant vaccines
5.4 Medicated feed additives
5.4.1 Antibiotics
5.4.2 Vitamins
5.4.3 Amino acids
5.4.4 Enzymes
5.4.5 Antioxidants
5.4.6 Prebiotics and probiotics
5.4.7 Minerals
5.4.8 Carbohydrates
5.4.9 Propandiol
Chapter 6 Market Estimates and Forecast, By Animal Type, 2021 - 2034 ($ Mn)
6.1 Key trends
6.2 Dogs
6.3 Cats
6.4 Horses
6.5 Other animal types
Chapter 7 Market Estimates and Forecast, By Route of Administration, 2021 - 2034 ($ Mn)
7.1 Key trends
7.2 Oral
7.3 Injectable
7.4 Topical
7.5 Other routes of administration
Chapter 8 Market Estimates and Forecast, By Distribution Channel, 2021 - 2034 ($ Mn)
8.1 Key trends
8.2 Veterinary hospital pharmacies
8.3 E-commerce
8.4 Retail pharmacies
Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Poland
9.3.7 Netherlands
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Taiwan
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 GCC Countries
9.6.3 Israel
Chapter 10 Company Profiles
10.1 Agrolabo
10.2 Boehringer Ingelheim International
10.3 Ceva Sante Animale
10.4 Chanelle Pharma
10.5 Dechra Pharmaceuticals
10.6 Elanco Animal Health Incorporated
10.7 Endovac Animal Health
10.8 HIPRA
10.9 Indian Immunologicals
10.10 Merck.
10.11 Norbrook
10.12 Symrise
10.13 Vetoquinol
10.14 Virbac
10.15 Zoetis
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security